
The oral azacitidine/cedazuridine combination was compared with subcutaneous azacitidine in the phase 3 portion of the AZTOUND trial.
Ovarian Cancer
Case: A 58-Year-Old Female With Progressive Ovarian Cancer
H & P
Imaging
Biopsy and Labs
Treatment
Follow-up






